Phase III Randomized Trial of Amifostine as a Radioprotector in Head and Neck Cancer - Concepedia

Concepedia

Publication | Closed Access

Phase III Randomized Trial of Amifostine as a Radioprotector in Head and Neck Cancer

830

Citations

27

References

2000

Year

David M. Brizel, Todd H. Wasserman, Michael Henke, Vratislav Strnad, Volker Rudat, Alain Monnier, François Eschwège, Jay Zhang, Lesley Russell, Wolfgang Oster,

Journal of Clinical Oncology

Abstract

Amifostine reduced acute and chronic xerostomia. Antitumor treatment efficacy was preserved.

References

	Year	Citations

Page 1